SYN-004 (ribaxamase), an oral beta-lactamase, mitigates antibiotic-mediated dysbiosis in a porcine gut microbiome model
Sheila Connelly(Synthetic Biologics (United States)), Michael Kaleko(Synthetic Biologics (United States)), Steve Hubert(Synthetic Biologics (United States)), Nur A. Hasan(Universitas Nahdlatul Ulama Indonesia), Rita R. Colwell(University of Maryland, Baltimore), Poorani Subramanian(National Institute of Allergy and Infectious Diseases), J. Andrew Bristol(Synthetic Biologics (United States))
Cited by 41
Related Papers
Report of the Ad Hoc Committee on Reconciliation of Approaches to Bacterial Systematics
|INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY|1987|7.3k
Emerging Marine Diseases--Climate Links and Anthropogenic Factors
|Science|1999|1.8k
Longitudinal analysis of microbial interaction between humans and the indoor environment
|Science|2014|962
Comparative genomics reveals mechanism for short-term and long-term clonal transitions in pandemic <i>Vibrio cholerae</i>
|Proceedings of the National Academy of Sciences|2009|394
Comprehensive benchmarking and ensemble approaches for metagenomic classifiers
|Genome biology|2017|389